Format

Send to

Choose Destination
Prenat Diagn. 2015 Oct;35(10):959-67. doi: 10.1002/pd.4637. Epub 2015 Sep 25.

Global perspectives on clinical adoption of NIPT.

Author information

1
Duke Science & Society, Duke University, Durham, NC, USA.
2
Genomic and Genetic Medicine, UCL Institute of Child Health and Great Ormond Street Hospital NHS Foundation Trust, London, UK.
3
Duke Global Health Institute, Duke University, Durham, NC, USA.

Abstract

OBJECTIVE:

The goals of this study were to assess global trends in clinical implementation of noninvasive prenatal testing (NIPT), as commercial tests are marketed increasingly worldwide, and to identify potential challenges for current or future use.

METHODS:

We surveyed clinicians from 46 countries about the availability of NIPT, their experiences with using NIPT, and their views on clinical, ethical, and legal issues affecting implementation in their countries.

RESULTS:

Forty-nine respondents from 28 countries completed the survey. The majority reported that NIPT is available in their country (n = 43) and that they offer NIPT in their current practice (n = 38). Eighteen respondents from 14 countries reported that there are plans to introduce NIPT into routine prenatal care in their country. Test prices varied widely, ranging from $350 to $2900, and several respondents observed that high test prices limited or restricted widespread use of NIPT. Responses varied both across and within countries regarding who is offered NIPT and what the overall screening protocol should be.

CONCLUSION:

This study provides a snapshot of current use and experiences with NIPT globally. It also highlights differences in service provision that exists both across and within countries, emphasizing the need for developing national and international implementation guidelines for NIPT.

PMID:
26085345
PMCID:
PMC5065727
DOI:
10.1002/pd.4637
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Wiley Icon for PubMed Central
Loading ...
Support Center